Skip to content | Skip to institutional links

Common menu bar links

Chemicals Management Plan Implementation Table at a Glance - 2011 to 2016
Regulatory Regime	Planned Government Action	Number of Substances	Rationale for Action	Timelines
Canadian Environmental Protection Act, 1999 (CEPA 1999)	Challenge Initiative: Completion of final Batch 11 and Batch 12 assessments. Risk management actions from the first phase of the CMP.	Batch 11 and Batch 12 final assessments and assessment of other chemical substances of interest. Risk management action milestones on all Challenge substances from the first phase of the CMP posing a risk.	These substances were identified as high priority for action following the categorization process. High priority substances were those that were: Persistent, bioaccumulative in the food chain, inherently toxic to the environment, and are known to be in commerce in Canada; and/or A high hazard to humans with a high likelihood of exposure to individuals in Canada.	Batch 11 was published in September 2011 and Batch 12 is scheduled to be published in November 2011. For those substances subject to risk management, risk management actions are to be taken within 3.5 years of the final assessment and statement that the Minister's propose that the substance be added to Schedule 1 of CEPA 1999.
	Petroleum Sector Stream: Completion of Petroleum Sector Stream assessments from the first phase of the CMP, and as needed, risk management actions.	164	These substances were considered a high priority following categorization, but were set aside from the Challenge program in the first phase of the CMP in order to be addressed under a sectoral approach.	Streams 1-3 remaining draft and final assessments to be published in 2011 to 2013. Stream 4 draft assessments to be published in 2013 to 2016. For relevant substances, risk management actions are to be taken within 3.5 years of the final assessment and statement that the Minister's propose that the substance be added to Schedule 1 of CEPA 1999.
	Azos and Benzidines: Completion of assessments of azo- and benzidine-based substances, and as needed, risk management actions.	Approximately 350.	Some of these substances may breakdown to produce certain aromatic amines or benzidines which may be of concern to human health or the environment.	Notice of Intent to assess and manage the risks of certain aromatic azo and benzidines substances to Canadians and their environment was published in Canada Gazette, Part I, on June 5, 2010. The first draft assessments to be published by early 2013.
	Groupings: Assessment of substances in the groupings initiative, and as needed, risk management actions.	Approximately 500.	Most of these substances were identified as part of the categorization process carried out under section 73 of CEPA, or because new information was received during the first phase of the CMP.	Notice of Intent to be published in Canada Gazette, Part I, in fall 2011. Draft assessments to be published starting 2013.
	DSL Inventory Update: Inventory Update (IU) on some substances on the Domestic Substances List (DSL)	Approximately 3000.	Updated information on substances in commerce in Canada, volumes and uses is required to support timely and strategic risk assessment and risk management decisions.	Survey launch planned for 2012.
	Rapid Screening: Rapid Screening of substances of lower concern identified from Phase 1 of the DSL IU (Quick Start) and from Phase 2 of the DSL IU.	The number of substances eligible for rapid screening will be determined based on the results of the inventory updates.	Based on information from the inventory updates, substances for which exposure is very low will be addressed efficiently.	Quick Start DSL IU: draft assessment to be published in 2012, final assessment to be published in 2013. Phase 2 DSL IU: draft and final assessments to be published in 2014 to 2015.
	Polymer Assessment: Assessment of polymeric substances and, as needed, risk management actions.	To be determined following the completion of Phase 2 of the DSL IU and a subsequent polymer specific survey.	These substances were identified as part of the categorization process carried out under section 73 of CEPA.	Actions as required.
	New Substances: Assessment of new substances.	Approximately 400-500 per year.	New Substance Notifications are required for all new substances introduced into the Canadian marketplace as per the New Substances Notification Regulations.	Ongoing.
	Products of Biotechnology: Screening assessment of organisms on the DSL.	Approximately 50.	Identified under section 74 of CEPA as requiring screening assessments.	First drafts to be published in fall 2011 and finalised through 2015.
	Monitoring: Ongoing monitoring of chemicals in the environment and humans.	Varies by monitoring program; up to 90 substances measured in human biomonitoring studies.	Monitoring provides essential information used to make sound and effective public health and environmental health policies and interventions, and helps to measure the effectiveness of Government actions to limit or reduce potential risks to humans and/or the environment.	Various ongoing initiatives, including reports on Cycle 2 of the Canadian Health Measures Survey (CHMS) in 2013 and Cycle 3 in 2015.
	Research: Research on effects, exposure and methods and tool development.	Varies by project and risk assessment needs.	Research is needed to better understand the exposure and effects of a variety of chemicals that were identified as priorities under the CMP, as well as to develop new tools to efficiently and effectively assess risks.	Maternal-Infant Research on Environmental Chemicals (MIREC) to be completed in 2012; and other research studies to be completed by March 2014. Launch 3rd cycle of research fund in 2013.
	Compliance and Enforcement	Depending on number of assessed and the resultant risk management outcomes.	Compliance promotion and enforcement activities ensure that regulatees are aware, understand and comply with regulatory requirements.	Ongoing.
	Drinking Water: Guidelines for Canadian Drinking Water Quality.	Approximately 5 per year (new or revised).	These health-based guidelines for existing, new and emerging contaminants that can impact health are developed through a Federal-Provincial-Territorial process. They are used by all jurisdictions in Canada to establish drinking water requirements to protect public health.	Ongoing.
Canada Consumer Product Safety Act(CCPSA)	Consumer Products: Increased surveillance of consumer products through analytical testing of levels of substances in products.		Levels of substances in products currently on the market are required to inform risk assessment, and to target risk management actions.	Ongoing.
Pest Control Products Act(PCPA)	Pesticides: Re-evaluation of older pesticides.	88 older active ingredients in 3500 substances.	The PCPA requires a cyclical review (15 years) of all pesticides.	2011 to 2016, or according to PCPA timelines.
	Pesticides: Initiate special reviews (see Regulatory Directive: Pest Management Regulatory Agency Re-evaluation Program - program 4).	As required.	Special reviews will be undertaken where there are reasonable grounds that health and environmental risks or value of a pesticide is unacceptable.	Action as required.
	Pesticides: Continue to monitor pesticide health and environmental incidents and take action as needed.	As required.	Monitoring of incidents helps identification of trends and additional information to support the risk assessment process and inform development of education and prevention.	Action as required.
Food and Drugs Act (F&DA) Substances	Substances in F&DA Products: CEPA Regulations for environmental assessment of substances in F&DA products.		These regulations will replace the New Substance Notification Regulations under CEPA for FDA substances and will outline the data requirements for industry so that government can conduct risk assessments and, as required, take risk management actions.	Regulations in Canada Gazette, Part I, by 2013. Development of guidance and program requirements in 2014. Regulations in Canada Gazette, Part II, by 2015.
	In Commerce List: Prioritization of substances on the In Commerce List (ICL).	Approximately 6000.	The In-Commerce List (ICL) is a list of substances contained in products that are regulated under the F&DA and that are not on the Domestic Substances List, but were in Canadian commerce between January 1, 1987 and September 13, 2001. Their prioritization is needed to identify which should be assessed for risks to the environment or indirect risks to human health.	Publish revised ICL and launch information surveys by 2013. Complete prioritization by 2016. Initiate the assessment of highest priority substances thereafter.
	Reassessment: Reassessment of previously assessed substances.		This will include food contaminants, food additives and food packaging materials to ensure they meet current standards.	Ongoing.